After investor attacks, Allergan's reviewing 'all options'—and this time it's urgent, CEO says - FiercePharma

After investor attacks, Allergan's reviewing 'all options'—and this time it's urgent, CEO says  FiercePharmaAllergan Chairman and CEO Brent Saunders gets to keep both his titles, thanks to a shareholder vote that broke in his favor. But he answered critics Tuesday ...